Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

INDIVIOR

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 32
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 47
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 32
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

RUBICON

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 26
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

ALEMBIC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 36
  • 0 comments

FDA approve MESALAMINE

Comment Full text

AJANTA PHARMA LTD

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve VARENICLINE TARTRATE

Comment Full text

IDORSIA PHARMA LTD

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve APROCITENTAN

Comment Full text

QILU

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 37
  • 0 comments

FDA approve AMIKACIN SULFATE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 38
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text
  • Previous
  • 499
  • 500
  • 501
  • 502
  • 503
  • Next

Search

News categories

  • Technical Exchange News(11751)
  • Event(4196)
  • SEC News(234451)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143030)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin